Bovine spongiform encephalopathy, multiple sclerosis, and Creutzfeldt-Jakob disease are probably autoimmune diseases evoked by Acinetobacter bacteria

Annals of the New York Academy of Sciences

Volumn 1050, Issue , 2005, Pages 417-428

  Ebringer, Alan ^a   Rashid, Taha ^a   Wilson, Clyde ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acinetobacter; Autoimmunity; Bovine spongiform encephalopathy; Creutzfeldt Jakob disease; Multiple sclerosis

Indexed keywords

ANTIBODY; AUTOANTIBODY; BRAIN PEPTIDE;

ACINETOBACTER; ALLERGIC ENCEPHALITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BOVINE SPONGIFORM ENCEPHALOPATHY; CLINICAL FEATURE; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; GRAY MATTER; HISTOPATHOLOGY; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRION DISEASE; PSEUDOMONAS; SCRAPIE; SHEEP; WHITE MATTER;

ACINETOBACTER; ANIMALIA; ATAXIA; BOVINAE; OVIS ARIES; PSEUDOMONAS; STREPTOCOCCUS;

EID: 23744459348     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1313.093     Document Type: Conference Paper

References (45)

1. WELLS, G.A., T. SCOTT, T. JOHNSON et al. 1987. A novel progressive spongiform encephalopathy in cattle. Vet. Rec. 121: 419-420.
2. PRUSINER, S.B. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216: 136-143.
3. WILL, R.G., J.W. IRONSIDE, M. ZEIDLER et al. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921-925.
4. DICKINSON, A.G. & V.M. MEIKLE. 1971. Host genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol. Gen. Genet. 112: 73-79.
5. PURDEY, M. 1994. Are organo-phosphates involved in the causation of bovine spongiform encephalopathy (BSE)? Hypothesis based upon literature review and limited trials on BSE cattle. J. Nutr. Med. 4: 43-82.
6. EBRINGER, A., J. PIRT, C. WILSON et al. 1997. Bovine spongiform encephalopathy: is it an autoimmune disease due to bacteria showing molecular mimicry with brain antigens? Environ. Health Perspect. 105: 1172-1174.
7. PATTISON, I.H. 1988. Fifty years with scrapie: a personal reminiscence. Vet. Rec. 123: 661-666.
8. PATTISON, I.H. & G.C. MILLSON. 1962. Distribution of the scrapie agent in the tissues of experimentally inoculated goats. J. Comp. Pathol. 72: 233-244.
9. AOKI, T., C.J. GIBBS, J. SOTELO et al. 1982. Heterogeneic autoantibody against neurofilament protein in the sera of animals with experimental kuru, Creutzfeldt-Jakob disease, and natural scrapie infection. Infect. Immun. 38: 316-324.
10. SOTELLO, J., C.J. GIBES & D.C. GAJDUSEK. 1980. Autoantibodies against axonal neurofilaments in patients with kuru and Creutzfeldt-Jakob disease. Science 210: 190-193.
11. REINDL, M., C. LININGTON, U. BREHM et al. 1999. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 122: 2047-2056.
12. PEARCE, J.M. 2002. Louis Pasteur and rabies: a brief note. J. Neurol. Neurosurg. Psychiatry 73: 82.
13. WESTONHURST, E. 1932. The effects of the injection of normal brain emulsion into rabbit with specific reference to the aetiology of the paralytic accidents of the antirabic treatment. J. Hyg. 32: 33-44.
14. ROSE, N.R. & E. WITEBSKY. 1956. Studies on organ specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J. Immunol. 76: 417-427.
15. MEDAWAR, P.B. 1958. The homograft reaction. Proc. R. Soc. (Lond.) 149: 145-166.
16. PRINEAS, J., C.S. RAINE & H. WISNIEWSKI. 1969. An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the nervous system. Lab. Invest. 21: 472-483.
17. RAINE, C.S., D.H. SNYDER, M.P. VALSAMIS et al. 1974. Chronic experimental allergic encephalomyelitis in inbred guinea pigs: an ultrastructural study. Lab. Invest. 31: 369-380.
18. EYLAR, E.H., J. CACCAM, J.J. JACKSON et al. 1970. Experimental allergic encephalomyelitis: synthesis of disease-inducing site of the basic protein. Science 168: 1220-1223.
19. WILSON, C., L.E. HUGHES, T. RASHID et al. 2003. Antibodies to Acinetobacter bacteria and bovine brain peptides, measured in bovine spongiform encephalopathy (BSE) in an attempt to develop an ante-mortem test. J. Clin. Lab. Immunol. 52: 23-40.
20. EBRINGER, A., J. PIRT, C. WILSON et al. 1998. Bovine spongiform encephalopathy: comparison between the "prion" hypothesis and the autoimmune theory. J. Nutr. Environ. Med. 8: 265-276.
21. EBRINGER, A., L. HUGHES, T. RASHID et al. 2005. Acinetobacter immune responses in multiple sclerosis-etiopathogenetic role and its possible use as a diagnostic marker. Arch. Neurol. 62: 33-36.
22. TIWANA, H., C. WILSON, J. PIRT et al. 1999. Autoantibodies to brain components and antibodies to Acinetobacter calcoaceticus are present in bovine spongiform encephalopathy. Infect. Immun. 67: 6591-6595.
23. WILSON, C., L. HUGHES, T. RASHID et al. 2004. Antibodies to prion and Acinetobacter peptide sequences in bovine spongiform encephalopathy. Vet. Immunol. Immunopathol. 98: 1-7.
24. EBRINGER, A., T. RASHID, C. WILSON et al. 2004. Multiple sclerosis, sporadic Creutzfeldt-Jakob disease, and bovine spongiform encephalopathy: are they autoimmune diseases evoked by Acinetobacter microbes showing molecular mimicry to brain antigens. J. Nutr. Environ. Med. 14(4): 293-302.
25. HUGHES, L.E., S. BONELL, R.S. NATT et al. 2001. Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-Acinetobacter-neurofilament antibody index. Clin. Diag. Lab. Immunol. 8: 1181-1188.
26. HUGHES, L.E., P.A. SMITH, S. BONELL et al. 2003. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein, and myelin oligodendrocyte glycoprotein in multiple sclerosis. J. Neuroimmunol. 144: 105-115.
27. GAY, D., G. DICK & G. UPTON. 1986. Multiple sclerosis associated with sinusitis: case-controlled study in general practice. Lancet i: 815-819.
28. CALLAGHAN, T.S. 1986. Multiple sclerosis and sinusitis. Lancet ii: 160-161.
29. CASIANO, R.R., S. COHN, E. VILLASUSO et al 2001. Comparison of antral tap with endoscopically directed nasal culture. Laryngoscope 111: 1333-1337.
30. EBRINGER, A., T. RASHID, C. WILSON et al. 2005. A possible link between multiple sclerosis and Creutzfeldt-Jakob disease based on clinical, genetic, pathological, and immunological evidence involving Acinetobacter bacteria. Med. Hypotheses 64: 487-494.
31. BARNETT, M.H. & J.W. PRINEAS. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55: 458-468.
32. LIBERSKI, P.P. & D.C. GAJDUSEK. 1997. Myelinated axon undergoes complete demyelination in the panencephalopathic, but it is merely subjected to the Wallerian degeneration in the polioencephalopathic type of transmissible spongiform encephalopathies. Pol. J. Pathol. 48: 163-171.
33. MACCHI, G., A.L. ABBAMONDI, G. DI TRAPANI et al. 1984. On the white matter lesions of the Creutzfeldt-Jakob disease: can a new subentity be recognized in man? J. Neurol. Sci. 63: 197-206.
34. DAVIES, G.R., L. RAMIO-TORRENTA, A. HADJIPROCOPIS et al. 2004. Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 75: 998-1002.
35. PRINEAS, J.W., W.I. MCDONALD & R.J.M. FRANKLIN. 2002. Demyelinating diseases. In Greenfield's Neuropathology, pp. 471-541. Arnold. London.
36. VAN EVERBROECK, B., E. DEWULF, P. PALS et al. 2002. The role of cytokines, astrocytes, microglia, and apoptosis in Creutzfeldt-Jakob disease. Neurobiol. Aging 23: 59-64.
37. LEWICKI, H., A. TISHON, D. HOMANN et al. 2003. T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies. J. Virol. 77: 3799-3808.
38. CORREALE, J. & M.M.B. MOLINAS. 2002. Oligoclonal bands and antibody responses in multiple sclerosis. J. Neurol. 249: 375-389.
39. GREEN, A.J. 2002. Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease. Neuropathol. Appl. Neurobiol. 28: 427-440.
40. BARTOSIK-PSUJEK, H. & J.J. ARCHELOS. 2004. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG. J. Neurol. 251: 414-420.
41. UK CREUTZFELDT-JAKOB DISEASE SURVEILLANCE UNIT. 1999. Eighth Annual Report [www.cjd.ed.ac.uk].
42. VENTERS, G.A. 2001. New variant Creutzfeldt-Jakob disease: the epidemic that never was. Br. Med. J. 323: 858-861.
43. EBRINGER, A., T. RASHID & C. WILSON. 2004. Bovine spongiform encephalopathy as an autoimmune disease evoked by Acinetobacter: implications for multiple sclerosis and Creutzfeldt-Jakob disease. In Infection and Autoimmunity, pp. 383-394. Elsevier. Amsterdam/New York.
44. ANDERSON, R.M., C.A. DONNELLY, N.M. FERGUSON et al. 1996. Transmission dynamics and epidemiology of BSE in British cattle. Nature 382: 779-788.
45. MILLER, D.H., S.R. HAMMOND, J.G. MCLEOD et al. 1990. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J. Neurol. Neurosurg. Psychiatry 53: 903-905.